Journal of gastrointestinal cancer 2015-06
Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.
Related Questions
There is some data on TMZ and 5FU based regimens, but convincing evidence is lacking. How would you approach this situation?
New answer by Medical Oncologist at Providence Cancer Institute (August 2, 2019)
In the absence of a clinical trial, I agree that FOLFIRI would be the best choice and is generally well tolerated as second line therapy. I would certainly offer tumor genotyp...
What therapy would you offer if the patient had a baseline grade 2 neuropathy?
New answer by Medical Oncologist at UH Seidman Cancer Center, Case Western Reserve University (August 28, 2021)
This is a very interesting question. I agree with the overall discussion with some points that need to be clear:
Did the pathology show mixed acinar and NEC with >30% of e...